Shattuck Labs (STTK) Other financing activities (2020 - 2026)
Shattuck Labs (STTK) posted quarterly Other financing activities of $59000.0 for Q1 2026, down 48.25% quarter-over-quarter from $114000.0 in Q4 2025.
Analysis
Shattuck Labs (STTK) Other financing activities (2020 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Other financing activities for 7 consecutive years, with $59000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $59000.0; the TTM figure through Mar 2026 stood at $198000.0 (down 69.35% YoY), while the FY2025 annual figure was $139000.0, down 88.92% from the prior year.
- Other financing activities eased to $59000.0 in Q1 2026 per STTK's latest filing, from $114000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $691000.0 in Q2 2024 and bottomed at -$72000.0 in Q4 2024.
- Historically, Other financing activities has averaged $141533.3 across 5 years, with a median of $33000.0 in 2023.
- On a YoY basis, Other financing activities climbed as much as 1993.94% in 2024 and fell as far as 117.73% in 2024.
- Shattuck Labs' Other financing activities stood at $27000.0 in 2022, then soared by 1403.7% to $406000.0 in 2023, then slumped by 117.73% to -$72000.0 in 2024, then jumped by 258.33% to $114000.0 in 2025, then slumped by 48.25% to $59000.0 in 2026.
- Business Quant data shows STTK's Other financing activities at $59000.0 in Q1 2026, $114000.0 in Q4 2025, and $17000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.33 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | -72,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 691,000.00 |
| Mar 31, 2024 | 609,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 290,000.00 |
| Sep 30, 2021 | 352,000.00 |
| Jun 30, 2021 | 1.26 Mn |
| Mar 31, 2021 | 31,000.00 |